Interaction of caveolin with 7-ketocholesterol

Atherosclerosis

Volumn 159, Issue 1, 2001, Pages 49-55

  Sleer, Leanne S ^a,b   Brown, Andrew J ^a   Stanley, Keith K ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

7 keto cholesterol; Caveolin; Cholesterol

Indexed keywords

7 OXOCHOLESTEROL; CAVEOLIN 1; CHOLESTEROL; LIPOSOME; OXIDIZED LOW DENSITY LIPOPROTEIN; OXYSTEROL; SUCROSE;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL SURFACE; CONTROLLED STUDY; FRACTIONATION; LIPID COMPOSITION; LIPID TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN PURIFICATION;

BLOTTING, WESTERN; CAVEOLIN 1; CAVEOLINS; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTEROL; KETOCHOLESTEROLS; LIPOSOMES; RECOMBINANT PROTEINS;

EID: 0034749013     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00486-5     Document Type: Article

References (26)

1. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine by Rous sarcoma virus-transformed fibroblasts
2. VIP21, a 21 kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles
3. Caveolae and sorting in the trans-Golgi network of epithelial cells
4. Caveolin-3 associates with developing T-tubules during muscle differentiation
5. VIP21/caveolin is a cholesterol-binding protein
6. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro
7. Oligomeric structure of caveolin: Implications for caveolae membrane organization
8. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol
9. Expression and characterisation of recombinant caveolin
10. Dominant negative caveolin selectively inhibits H-Ras function by disrupting cholesterol-rich domains
11. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation
12. Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells
13. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells
14. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin
15. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of src tyrosine kinases
16. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1
17. Src family kinase activation in glycosphingolipid rich membrane domains of endothelial cells treated with oxidised low density lipoprotein
18. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol
19. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblasts monolayers
20. Regulation of caveolin and caveolae by cholesterol in MDCK cells
21. Characterisation of a cytosolic heat shock protein-caveolin chaperone complex
22. The low-density lipoprotein pathway and its relation to atherosclerosis
23. Oxysterols and atherosclerosis
24. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae
25. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae
26. Signalling functions of protein palmitoylation